JPH02229171A - Cyclopenta(1,2-c)-3-pyrazolecarboxylic acid derivative - Google Patents

Cyclopenta(1,2-c)-3-pyrazolecarboxylic acid derivative

Info

Publication number
JPH02229171A
JPH02229171A JP4933089A JP4933089A JPH02229171A JP H02229171 A JPH02229171 A JP H02229171A JP 4933089 A JP4933089 A JP 4933089A JP 4933089 A JP4933089 A JP 4933089A JP H02229171 A JPH02229171 A JP H02229171A
Authority
JP
Japan
Prior art keywords
group
formula
alkyl
compound
cyclopenta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4933089A
Other languages
Japanese (ja)
Other versions
JP2743441B2 (en
Inventor
Itaru Okada
至 岡田
Kenji Yoshida
健二 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP1049330A priority Critical patent/JP2743441B2/en
Publication of JPH02229171A publication Critical patent/JPH02229171A/en
Application granted granted Critical
Publication of JP2743441B2 publication Critical patent/JP2743441B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

NEW MATERIAL:A cyclopenta[1,2-C]-3-pyrazolecarboxylic acid derivative shown by formula I (R<1> is 1-4C alkyl; R<2> is H or 1-3C alkyl; R<3> is H or methyl; R4 is R or 1-4C alkyl with the proviso that when R<1> is methyl or ethyl and both R<2> and R<3> are H, R<4> is 2-4C alkyl). EXAMPLE:2,6-Dimethylcyclopenta[1,2-C]-3-pyrazolecarboxylic acid ethyl ester. USE:An intermediate for drugs, agricultural chemicals, especially insecticides, acaricides and fungicides. PREPARATION:For example, a compound shown by formula II (Z is 1-4C alkyl) is reacted with a hydrazine compound to give a compound shown by formula Ia, one of compounds shown by formula I. Then this compound is hydrolyzed with an alkali to give a compound shown by formula Ib, one of compounds shown by formula I.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は新規なシクロペンタ[/.2−Cl −3−ピ
ラゾールカルボン酸およびそのエステル類に関する。詳
しくは、医薬、農薬、特に殺虫、殺ダニ剤および殺菌剤
の中間体として有用な化合物に関するものである。
[Detailed Description of the Invention] [Industrial Application Field] The present invention provides a novel cyclopenta[/. The present invention relates to 2-Cl-3-pyrazolecarboxylic acid and its esters. In particular, it relates to compounds useful as intermediates for medicines, agricultural chemicals, especially insecticides, acaricides, and fungicides.

〔従来の技術および発明が解決しようとする課題〕[Problems to be solved by conventional technology and invention]

ピラゾール系化合物は、医薬、農薬として有用な化合物
であり、その優れた薬効が、近年、注目されている。特
に、ビラゾール環に種々の置換基を導入することによシ
、薬効を改良する得るビラゾール系化合物は5人手が困
難であり、これ丑でそのような目的で製造丑たは利用さ
れた化合物は、ほとんど知られていない。
Pyrazole compounds are useful compounds as medicines and agricultural chemicals, and their excellent medicinal efficacy has attracted attention in recent years. In particular, it is difficult to produce virazole compounds whose medicinal efficacy can be improved by introducing various substituents into the virazole ring, and the compounds that have been manufactured or used for this purpose are , little known.

〔課題を解決するだめの手段〕[Failure to solve the problem]

本発明者らは、上記課題に鑑み、鋭意検討した結果、有
用な新規中間体であるビラゾールヵルボン酸誘導体を見
出し5本発明を完成するに至った。
In view of the above-mentioned problems, the present inventors conducted extensive studies and as a result discovered a virazole carboxylic acid derivative which is a useful new intermediate and completed the present invention.

すなわち本発明の要旨は、下記一般式(I,)で表され
るシクロペンタ〔八.2−C]−3−ピラゾールカルボ
ン酸誘導体に存する。
That is, the gist of the present invention is to provide cyclopenta [8. 2-C]-3-pyrazolecarboxylic acid derivatives.

R1 (上記式中、R1はC,〜C4のアルキル基を示し、R
2は水素原子まだはC1〜C3のアルキル基を示いR3
は水素原子まだはメチル基を示し、R4は水素原子また
は01〜clのアルキル基を示す。ただし、R1がメチ
ル基またはエチル基であり、且っR2と几3が共に水素
原子を示す場合、R4はC2〜qのアルキル基を示す。
R1 (In the above formula, R1 represents a C, to C4 alkyl group, R
2 represents a hydrogen atom or a C1-C3 alkyl group; R3
represents a hydrogen atom or a methyl group, and R4 represents a hydrogen atom or an alkyl group of 01 to cl. However, when R1 is a methyl group or an ethyl group, and R2 and R3 both represent a hydrogen atom, R4 represents a C2-q alkyl group.

) 以下、本発明を詳細に説明する。) The present invention will be explained in detail below.

一般式CI)においてR1はメチル基、エチル基、n−
プロビル基、イソブロビル基、n−プチル基,インブチ
ル基、sec−ブチル基、t−プチル基等のC1〜C4
の直鎖寸たは分岐鎖アルキル基を示す。R2ぱ水素原子
;メチル基、エチル基、n−フロピル基、イソプロビル
基等のc1〜c3の直鎖または分岐鎖アルキル基を示す
。R3は水素原子またはメチル基を示す。R4は水素原
子;メチル基、エチル基、n〜プロビル基,イソブロビ
ル基、n−ブチル基、インブチル基,sec−ブテル基
、t−プチル基等のC,〜c4の直鎖または分岐鎖アル
キル基を示す。但し、R1がメチル基またはエチル基で
あり、且っR2とR3が共に水素原子である場合、厭は
エチル基、n−プロビル基、イングロビル基、n−ブチ
ル基、インブチル基.  sec−ブチル基、t−プチ
ル基等のc2〜C4の直鎖または分岐鎖アルキル基であ
る。
In the general formula CI), R1 is a methyl group, an ethyl group, an n-
C1 to C4 of probyl group, isobrobyl group, n-butyl group, inbutyl group, sec-butyl group, t-butyl group, etc.
represents a straight-chain or branched alkyl group. R2 hydrogen atom; represents a C1 to C3 straight or branched alkyl group such as a methyl group, an ethyl group, an n-furopyl group, or an isoprobyl group. R3 represents a hydrogen atom or a methyl group. R4 is a hydrogen atom; C, ~c4 straight or branched alkyl group such as methyl group, ethyl group, n~probyl group, isobrobyl group, n-butyl group, inbutyl group, sec-butyl group, t-butyl group, etc. shows. However, if R1 is a methyl group or an ethyl group, and R2 and R3 are both hydrogen atoms, the preference is an ethyl group, n-probyl group, inglovir group, n-butyl group, inbutyl group. It is a C2 to C4 straight chain or branched alkyl group such as a sec-butyl group or a t-butyl group.

前記一般式(1)で表される本発明の化合物のうちエス
テル類(Ia)およびカルボン酸類(Ib)は、例えば
下記反応式に従って製造することができる。
Among the compounds of the present invention represented by the general formula (1), esters (Ia) and carboxylic acids (Ib) can be produced, for example, according to the following reaction formula.

= 3 − − 4 一 (上記反応式中L R’ L R2およびR3は前記一
般式(I)で定義したとおシであシ、ZはC1〜qのア
ルキル基を示す〕 すなわち、上記一般式<m)で表される化合物とヒドラ
ジン類を水またはメタノール、エタノール、イングロパ
ノール等のアルコール溶媒中、70〜30℃、好ましく
は20〜30℃で反応させることによシ、上記一般式(
Ia)の化合物を容易に得ることができる。
= 3 - - 4 - (in the above reaction formula, LR' L R2 and R3 are as defined in the above general formula (I), Z represents an alkyl group of C1 to q)] That is, the above general formula The above general formula (
Compound Ia) can be easily obtained.

また、上記一般式(Ia)で表されるエステル類をアル
カリの存在下、水中またはメタノール、エタノール等の
アルコール中もしくはアルコールと水の混合溶媒中、.
20〜/θθ℃で加水分解することにより、上記一般式
(Ib)で表されるカルボン酸類を得ることができる。
Alternatively, the ester represented by the general formula (Ia) may be mixed in water, in an alcohol such as methanol or ethanol, or in a mixed solvent of alcohol and water in the presence of an alkali.
By hydrolyzing at 20 to /θθ°C, carboxylic acids represented by the above general formula (Ib) can be obtained.

アルカリとしては、水酸化ナトリウム、水酸化カリウム
、炭酸ナトリウム、炭酸カリウム等が関用される。
As the alkali, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc. are used.

上記一般式( Ia)で表される化合物は、下記反応式
に従っても製造することができる。
The compound represented by the above general formula (Ia) can also be produced according to the following reaction formula.

Rl (Ia) (土記反芯式中、R’.R2およびR3は前記一般式C
I)で定義したとおシであシ、ZはC,−C4のアルキ
ル基を示すp すなわち、上記一般式(II,)の化合物とヒドラジン
ヒドラートを水またはメタノール、エタノール,イング
ロパノール等のアルコール溶媒中、O−.5′θ℃、好
ましくは70〜30℃で反応させることによ)、上記一
般式(III,)で表される化合物を得ることができる
。得られた上記一般式(II−f)で表される化合物と
アルキル化剤を塩化メチレン、クロロホルム,四塩化炭
素、八一−ジクロロエタン等のハロゲン化炭化水素;ベ
ンゼン、トルエン、キシレン等の芳香族炭化水素;N,
N−ジメチルホルムアミド、N−メチルピロリドン、ジ
メチルスルホキシド等の溶媒中、または無溶媒中で/0
〜/00゜C、好ましくは一0〜SO℃で反応させるこ
とにより、上記一般式(Ia)で表される化合物を容易
に得ることができる。アルキル化剤としては、ジメチノ
レ硫酸、ジエチル硫酸、ジグロピル硫酸、ジブチノレ硫
酸、臭化メチル、臭化エチル、臭化プロビノレ、臭化ブ
チル、ヨウ化メチル、ヨウ化エチノレ5ヨウ化プロビル
、ヨウ化ブチル、塩化メチル、塩化エチル、塩化プロビ
ル、塩化ブチル等が関用可能である。
Rl (Ia) (In the Doki anti-shin formula, R'.R2 and R3 are the above general formula C
p as defined in I), Z represents a C, -C4 alkyl group. That is, the compound of the above general formula (II,) and hydrazine hydrate are mixed with water or methanol, ethanol, ingropanol, etc. In alcoholic solvent, O-. By reacting at 5'θ°C, preferably 70 to 30°C), a compound represented by the above general formula (III,) can be obtained. The obtained compound represented by the above general formula (II-f) and an alkylating agent are mixed with halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, and 81-dichloroethane; aromatic compounds such as benzene, toluene, and xylene. Hydrocarbon; N,
In a solvent such as N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, or without a solvent /0
The compound represented by the above general formula (Ia) can be easily obtained by reacting at ~/00°C, preferably 10~SO°C. Examples of the alkylating agent include dimethynole sulfate, diethyl sulfate, diglopyr sulfate, dibutynole sulfate, methyl bromide, ethyl bromide, provinole bromide, butyl bromide, methyl iodide, ethynole iodide, probyl iodide, butyl iodide, Methyl chloride, ethyl chloride, probyl chloride, butyl chloride, etc. can be used.

なお、上記一般式(■)で表される化合物は、Org.
Syntli. , u , jf 3 /に記載の方
法に準じて容易に合成することができる。
In addition, the compound represented by the above general formula (■) is the compound represented by Org.
Syntli. , u, jf 3 /.

〔実施例〕〔Example〕

次に本発明を更に具体的に説明するが、本発明はその要
旨を越えない限シ、以下の例に限定されるものではない
Next, the present invention will be explained in more detail, but the present invention is not limited to the following examples unless it exceeds the gist thereof.

実施例/−] リ λ,A−ジメチルシクロペンタ〔八a−C:]−3−ピ
ラソールカルボン酸エチルエステルの製造 コーケトシクロベンチルグリオキザル酸エチルエステル
41g./グのエタノール!00ml溶液にλO〜.2
5℃でメチルヒドラジン/2.7?を滴下し、同腐度で
S時間攪拌し、減圧下濃縮した。次いでトルエンで抽出
後、水洗した。トルエン層を濃縮し、ヘキサンを加え/
0℃まで冷一 〒 一 却し、副生析出結晶をP別した。沢液を濃縮後、蒸留し
I’ll) / / 3 〜/ / 5゜C/θ.7m
mHflの表一/記載の化合物(扁3).2グ.左2を
得た。得られた化合物のN M R .&よびIRスペ
クトラムを以下に示す。    ,[・ ’H−NI’viR(CDCI3)δppm  ;  
/.29(d)3H./.3?(t)3H. /.g 
〜3、3(m)3H, lI−/j(s)3H+ 弧3
3(q)2HIR( NaCI ) ; / 7 2 
0B ’実施例λ コ,A−ジメチルシクロベンタ[/.2−C) −3−
ピラゾールカルボン酸の製造 コ,乙一ジメチルシクロペンタl:/,2−C)−3−
ピラゾールカルボン酸エチルエステル/L?62と水酸
化ナトリウムg.01のyoml水溶液を/時間加熱還
流した。室湛に冷却後、塩酸で酸性にし析出物をr取し
た。減圧下左O℃で乾燥し表−/記載の化合物(扁ユ)
 / 5./ ?、mp!7/〜/73℃を得た。得ら
れた化合物のNMRおよびIRスベクトラムを以下に示
す。
Example/-] Preparation of λ,A-dimethylcyclopenta[8a-C:]-3-pyrazolecarboxylic acid ethyl ester Coketocyclobentylglyoxalic acid ethyl ester 41 g. /g ethanol! λO~.00ml solution. 2
Methylhydrazine/2.7 at 5℃? was added dropwise, stirred at the same degree of rot for S hours, and concentrated under reduced pressure. Next, it was extracted with toluene and washed with water. Concentrate the toluene layer and add hexane/
The mixture was cooled to 0° C., and the by-product precipitated crystals were separated from P. After concentrating the filtrate, it is distilled to a temperature of 3 to 5 degrees C/θ. 7m
Compounds listed in Table 1 of mHfl (Ban 3). 2g. Got 2 on the left. NMR of the obtained compound. & and the IR spectrum are shown below. , [・'H-NI'viR(CDCI3)δppm;
/. 29(d)3H. /. 3? (t)3H. /. g
~3, 3(m)3H, lI-/j(s)3H+ Arc 3
3(q)2HIR(NaCI); /7 2
0B 'Example λ co,A-dimethylcyclobenta[/. 2-C) -3-
Production of pyrazole carboxylic acid, dimethylcyclopenta:/, 2-C)-3-
Pyrazole carboxylic acid ethyl ester/L? 62 and sodium hydroxide g. A yoml aqueous solution of 01 was heated to reflux for 1 hour. After cooling to room temperature, the mixture was acidified with hydrochloric acid and the precipitate was collected. Dry at 0°C under reduced pressure and prepare the compound listed in the table (Banyu).
/ 5. / ? ,mp! 7/~/73°C was obtained. The NMR and IR spectra of the obtained compound are shown below.

’H−NMR(CDCI3)δpIJm  ;  /−
2!rcd)3H. /.9!;(m)IH.2.47
 〜3.0(m)3H.  3./.!t(m)/H,
  +!./&(S).?HIR(KBr);  iク
iocrn’実施例3 !−メチルシクロペンタ〔/,コーC〕−3−ピラゾー
ルカルボン酸エチルエステルの製造コーケトシクロベン
チルグリオキザル酸エチルエステルig.qタのエタノ
ールiooml溶液中にヒドラジンヒドラート!;.0
 ?を滴下し7時間攪拌後、析出物を沢別した。沢液を
濃縮後、残渣をトルエンで抽出し水洗した。減圧下トル
エンを留去し油秋物を得だ。次に本油状物中にジメチル
硫酸一3.27を70℃で滴下した。
'H-NMR (CDCI3) δpIJm; /-
2! rcd)3H. /. 9! (m) IH. 2.47
~3.0(m)3H. 3. /. ! t(m)/H,
+! .. /&(S). ? HIR(KBr); ikuiocrn'Example 3! -Methylcyclopenta[/, CoC]-3-Pyrazolecarboxylic acid ethyl ester production Coketocyclobentylglyoxalic acid ethyl ester ig. Hydrazine hydrate in qta ethanol iooml solution! ;. 0
? was added dropwise, and after stirring for 7 hours, the precipitate was separated. After concentrating the slurry, the residue was extracted with toluene and washed with water. Toluene was distilled off under reduced pressure to obtain an oily substance. Next, 3.27 g of dimethyl sulfate was added dropwise to the oil at 70°C.

ク0〜50℃で3時間攪拌後、室湛に冷却し、氷水中に
注ぎ、炭酸ナトリウムを加えてpHをg〜9にしだ。油
秋物を酢酸エチルで抽出し、水洗後濃縮した。残直をシ
リカゲム力ラムクλマトグラフイーで精製し、表一/記
載の化合物( A / ) 9 0グ、mpグg〜ケ9
℃を得た。得られた化合物のNMRおよびIRスペクト
ラムを以下に示す。
After stirring at 0 to 50°C for 3 hours, the mixture was cooled to room temperature, poured into ice water, and sodium carbonate was added to adjust the pH to g to 9. The oil was extracted with ethyl acetate, washed with water, and then concentrated. The residue was purified by silica gel lambda chromatography, and the compounds listed in Table 1 (A/) 90g, mpg~ke9
℃ was obtained. The NMR and IR spectra of the obtained compound are shown below.

’H−NMR( CDC13)δppm  ;  /.
35(t)3■{,;1.3 〜2.9 & (m, 
 乙H). グ,/(S,+3HI  グ.y.ff(
q)JHIR(KBr )  ; / 7 / 0(B
 ’コ 実施例グ   J]・ 実施例/〜3と同様にして表一/記載の化合物を得た。
'H-NMR (CDC13) δppm; /.
35(t)3■{, ;1.3 ~2.9 & (m,
Otsu H). g, /(S, +3HI g.y.ff(
q) JHIR (KBr); / 7 / 0 (B
[Example J] - Compounds listed in Table 1 were obtained in the same manner as in Examples 1 to 3.

表 / 一11− 一12 なお、表一/に記載した一部の化合物につき、そのNM
RおよびIRスペクトラムを以下に示す。
Table/111-112 For some compounds listed in Table 1/, their NM
The R and IR spectra are shown below.

A グ ’ H NMR ( CDCI−s )δppm ; 
/./−/.A(m) 9H+.2./ 〜.2.3 
(m) ,!H. 2.6 〜.3.’l (m) 2
 H. ’I./ ( s ) 3H.グー35(q)
λH IR(NaCI ) ;  / 7 / OcIrL扁
 g 1H NMR(CC14)δppH1  ;  /..2〜/
.5(m)乙I七.2.’l (m) .2H. 2.
7 (m,) &H, ll−.2 5 (q ) .
2H.q.グ5(q)JH IR(NaCl,);  / 7.20C:rn’扁 
タ 1H NMR(CDC13)δppm; /.3!;(m,)9H. .2./ 3 〜2.9 0 (m,)乙H,’1.3
 (q,)2H.5.5 (m)/HIR(NaCl)
; /70ACa’ 扁 / 0 ’H−NMR(CDCi3)δpprn  ;  /J
 (d+  乙■リ,2.3 〜.2.9 !i(m)
乙H, !.’l 3 (m,) / H, g.0 
左(bs,) /HIR(KBr)  ;  / 70
 盪薄’扁 l S ’H−NMR(CDC]3)δppm ;  /.0(
t).3H./.2!;(d)3H./J 〜.2./
 (m)JH.2.? 〜.2.9(m)3H..7.
/ 左(m)/H,ク./j−(S)3H.4’−+2
Ct)2HIR(NaCI);  / 720(B ’
j!6// ’ H  NMR ( CJ)CI3 )δppm  
;  θ.9(t)3H/J〜/.タ(m+).2H.
.2..2〜.2.9 (m) 6H.’AI !;−
4.A (rn)Ll{IR(NaC].);  / 
7ノ6cm ’/.4t (m)夕H, I6/6 ’H  NMR(CDCIs)δppm  ;  人,
l 〜/.lI(H1)デH,/.7 〜.2..?(
m)/H,r.3〜.2.9(m,)3H..?.i!
; (m)/H.’I./ (s ) .?H, 3.
/ !r (m) /HIR(NaCI);  / 7
/OCrn’A. /  2 ’H−NMR(CDCI3)δppm  +,  θ9
!(t).?H/./ 〜2.0 (m)4tI{. 
.2..3 〜3.0 (m)乙H, 41.!; (
 t ) .xH,7J(bs)/H IR(KBr) ;  / 7/ 9(B ’A/7 ’H−NMR(CC1.4)δppm  ; 0.9!
;(t)3H./..2(d).?Hi./ 〜.2.
/  (m).rH,  2.乙!; (m).?H,
  3.Oj (m,)/H,4t.0左(s)31−
{.!..2(t).21−1IR(NaCl )  
;  / 7 2 0crn ’扁 / 3 用 NMR(CDC13)δppm : /夕(t)JH /.乙(6)yH 3.05〜.2..グ(In)乙H.  グ.グ左(q
.)λHIR(NaC1);  / 7 25cm ’
l5 A/g ’H−NMR(CC14)δppm   ;  0−9
!r(t)3H././3 〜/.4t(m)乙H, 
/.lI〜u.2 (m,) 3H.2..2 〜2.
g 5 (m).3H. .3−0 3 (m) /H
, 4t.0 3 ( s).?H夕.タ左(+11.
  /H) I R (NaCリ;y7/!cm’ 扁 / 9 ’H−NMR C CCI4,lδTJpm   ; 
 /..2(d).?H,  /J(s)タH/.9 
(ro) / H, 2..3 〜.2.7 !r (
m)3H. 3.0 (m) /H,グ.0(S)JH IR(NaC1); / ?/OCTL’〔発明の効果
〕 本発明のシクロペンタ〔/,一一〇〕−3−ピラゾール
カルボン酸誘導体は、ビラゾーノレ系殺虫、殺ダニ剤お
よび殺菌剤の中間体として有用であシ、その工業的価値
は高い。
A Gu'H NMR (CDCI-s) δppm;
/. /-/. A(m) 9H+. 2. / ~. 2.3
(m) ,! H. 2.6 ~. 3. 'l (m) 2
H. 'I. / (s) 3H. Goo 35 (q)
λH IR (NaCI); / 7 / OcIrL-g 1H NMR (CC14) δppH1; /. .. 2~/
.. 5(m) Otsu I7. 2. 'l (m). 2H. 2.
7 (m,) &H, ll-. 2 5 (q).
2H. q. G5 (q) JH IR (NaCl, ); / 7.20C:rn' flat
Ta1H NMR (CDC13) δppm; /. 3! ;(m,)9H. .. 2. / 3 ~ 2.9 0 (m,) Otsu H,'1.3
(q,)2H. 5.5 (m)/HIR(NaCl)
; /70ACa' / 0'H-NMR (CDCi3) δpprn ; /J
(d+ Otsu■li, 2.3 ~.2.9 !i(m)
Otsu H,! .. 'l 3 (m,) / H, g. 0
Left (bs,) /HIR (KBr); /70
/. 0(
t). 3H. /. 2! (d) 3H. /J ~. 2. /
(m) JH. 2. ? ~. 2.9 (m) 3H. .. 7.
/ Left (m) / H, Ku. /j-(S)3H. 4'-+2
Ct)2HIR(NaCI); /720(B'
j! 6//' H NMR (CJ)CI3)δppm
; θ. 9(t)3H/J~/. Ta (m+). 2H.
.. 2. .. 2~. 2.9 (m) 6H. 'AI! ;-
4. A (rn)Ll{IR(NaC].); /
7 no 6cm'/. 4t (m) Evening H, I6/6'H NMR (CDCIs) δppm; Human,
l ~/. lI(H1)deH,/. 7 ~. 2. .. ? (
m)/H, r. 3~. 2.9(m,)3H. .. ? .. i!
; (m)/H. 'I. / (s). ? H, 3.
/! r (m) /HIR(NaCI); /7
/OCrn'A. / 2'H-NMR (CDCI3) δppm +, θ9
! (t). ? H/. / ~2.0 (m)4tI{.
.. 2. .. 3 ~3.0 (m) Otsu H, 41. ! ; (
t). xH, 7J (bs)/H IR (KBr); / 7/ 9 (B'A/7'H-NMR (CC1.4) δppm; 0.9!
;(t)3H. /. .. 2(d). ? Hi. / ~. 2.
/ (m). rH, 2. Otsu! ; (m). ? H,
3. Oj (m,)/H, 4t. 0 left (s) 31-
{. ! .. .. 2(t). 21-1IR (NaCl)
; / 7 2 0crn' / 3 NMR (CDC13) δppm: / evening (t) JH /. Otsu (6)yH 3.05~. 2. .. (In) Otsu H. G. G left (q
.. )λHIR(NaC1); /7 25cm'
l5 A/g'H-NMR (CC14) δppm; 0-9
! r(t)3H. /. /3 ~/. 4t(m) Otsu H,
/. lI~u. 2 (m,) 3H. 2. .. 2 ~2.
g 5 (m). 3H. .. 3-0 3 (m) /H
, 4t. 0 3 (s). ? H evening. Ta left (+11.
/H) I R (NaCl;y7/!cm' flat /9'H-NMR C CCI4,lδTJpm;
/. .. 2(d). ? H, /J(s)taH/. 9
(ro) / H, 2. .. 3 ~. 2.7! r (
m) 3H. 3.0 (m) /H,g. 0(S)JH IR(NaC1); /? /OCTL' [Effects of the Invention] The cyclopenta[/,110]-3-pyrazolecarboxylic acid derivative of the present invention is useful as an intermediate for villazonole insecticides, acaricides, and fungicides, and is suitable for industrial use. The value is high.

出 願 人  三菱化成株式会社 代 理 人  弁理士 長谷J ほか/名Sender: Mitsubishi Kasei Corporation Representative Patent Attorney Hase J Others/names

Claims (1)

【特許請求の範囲】[Claims] (1)下記一般式( I )で表されるシクロペンタ〔1
,2−C〕−3−ピラゾールカルボン酸誘導体。 ▲数式、化学式、表等があります▼・・・( I ) (上記式中、R^1はC_1〜C_4のアルキル基を示
し、R^2は水素原子またはC_1〜C_3のアルキル
基を示し、R^3は水素原子またはメチル基を示し、R
^4は水素原子またはC_1〜C_4のアルキル基を示
す。ただし、R^1がメチル基またはエチル基であり、
且つR^2とR^3が共に水素原子である場合、R^4
はC_2〜C_4のアルキル基を示す。)
(1) Cyclopenta [1] represented by the following general formula (I)
,2-C]-3-pyrazolecarboxylic acid derivative. ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(I) (In the above formula, R^1 represents an alkyl group of C_1 to C_4, R^2 represents a hydrogen atom or an alkyl group of C_1 to C_3, R^3 represents a hydrogen atom or a methyl group, and R
^4 represents a hydrogen atom or an alkyl group of C_1 to C_4. However, R^1 is a methyl group or an ethyl group,
And when R^2 and R^3 are both hydrogen atoms, R^4
represents a C_2 to C_4 alkyl group. )
JP1049330A 1989-03-01 1989-03-01 Cyclopenta [1,2-C] -3-pyrazolecarboxylic acid derivative Expired - Fee Related JP2743441B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1049330A JP2743441B2 (en) 1989-03-01 1989-03-01 Cyclopenta [1,2-C] -3-pyrazolecarboxylic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1049330A JP2743441B2 (en) 1989-03-01 1989-03-01 Cyclopenta [1,2-C] -3-pyrazolecarboxylic acid derivative

Publications (2)

Publication Number Publication Date
JPH02229171A true JPH02229171A (en) 1990-09-11
JP2743441B2 JP2743441B2 (en) 1998-04-22

Family

ID=12827979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1049330A Expired - Fee Related JP2743441B2 (en) 1989-03-01 1989-03-01 Cyclopenta [1,2-C] -3-pyrazolecarboxylic acid derivative

Country Status (1)

Country Link
JP (1) JP2743441B2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307801A1 (en) * 1987-09-11 1989-03-22 Mitsubishi Kasei Corporation Pyrazole derivative and insecticidal and miticidal composition containing the derivative as active ingredient

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307801A1 (en) * 1987-09-11 1989-03-22 Mitsubishi Kasei Corporation Pyrazole derivative and insecticidal and miticidal composition containing the derivative as active ingredient

Also Published As

Publication number Publication date
JP2743441B2 (en) 1998-04-22

Similar Documents

Publication Publication Date Title
Xie et al. Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6, 7-dihydropyrazolo [1, 5-a] pyrazin-4 (5H)-one derivatives
JPS61207369A (en) Benzoic acid intermediate having three substituents
WO2014117452A1 (en) Synthesis and application of difluoro methylene phosphorus inner salt
WO2024152641A1 (en) Preparation method for 3-chlorobicyclo[3.2.1]-3-octen-2-ol
CN106631885B (en) A method of preparing 4- formaldoxime yl benzoic acid ester derivatives
CN110563726A (en) Preparation method of tert-butyl-7, 9-dioxy-2, 6-diazaspiro [4.5] decane-2-formic acid ester
JPH02229171A (en) Cyclopenta(1,2-c)-3-pyrazolecarboxylic acid derivative
JPS6045631B2 (en) Production method of phenylglyoxalic acid ester
CN113816925A (en) A trematopsin 3 &#34;-tert-butyl-4 &#39;- (2-hydroxyethoxy) -4&#34; -pyrrolidin-1-yl [1, 1&#39;; process for preparing 3 &#39;, 1&#39; ] -terphenyl-4-carboxylic acid
JP5448572B2 (en) Acetyl compound, method for producing the acetyl compound, and method for producing a naphthol compound using the acetyl compound
JPS5927343B2 (en) Synthesis method of 3-aminoisoxazoles
CZ299711B6 (en) Process for preparing 6-aryl-5,6-dioxohexanoic acid
WO2003014067A1 (en) PROCESS FOR PRODUCING ß-OXONITRILE COMPOUND OR ALKALI METAL SALT THEREOF
CN111978264B (en) Industrial production method of deferasirox
CN111574448B (en) Preparation method of phenyl tetrahydroisoquinoline
WO2024190464A1 (en) Method for producing acrylic acid derivative
JP3855686B2 (en) 3,3-dialkoxy-2-hydroxyimino derivative and process for producing the same
JPH07118238A (en) Production of 1-alkyl-5-pyrazolecarboxylic acid esters
JPS58154537A (en) Preparation of hydroxybenzoic acid lower aralkyl ester
JP2003113153A (en) METHOD FOR PRODUCING beta-OXONITRILE DERIVATIVE OR ALKALI METAL SALT THEREOF
JP4013772B2 (en) 2-Hydroxyimino-3-oxopropionitrile and process for producing the same
JPS5810530A (en) Manufacture of unsaturated gem-dihalogen compound
JPS603382B2 (en) Novel production method for isoindoline derivatives
JP3864763B2 (en) 3-halo-2-hydrazono-1-hydroxyiminopropane derivative and process for producing the same
CN115894518A (en) Synthetic method of pinoxaden metabolite M3

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080206

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090206

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees